Information Update – International clinical trials, including trials in Canada, are being stopped due to serious adverse events with the drug Zydelig, in combination with other cancer drugs

OTTAWA, March 17, 2016 /CNW/ – Health Canada is informing Canadians and health care professionals of four Canadian clinical trials, involving the cancer medicine Zydelig (idelalisib) in combination with other cancer medicines, being stopped after reports of an increased rate of…